✦ LIBER ✦

Retrospective review of mitomycin C use as third-line chemotherapy in metastatic colorectal cancer

✍ Scribed by Wei CHUA; Philip BEALE; Melissa LEUNG; Stephen CLARKE

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mitomycin-C as third- or fourth-line pal

✍ Brown⁎, N.S.; Braun, M. 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 61 KB

Mitomycin-C and capecitabine as third-li

✍ Do Hyoung Lim; Young Suk Park; Byeong-Bae Park; Sang Hoon Ji; Jeeyun Lee; Keon W 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 200 KB

Mitomycin-C, VP16-213 combination as thi

✍ G. Perez Manga; P. L. Madrigal Alonso; H. Alburquerque Carbuccia 📂 Article 📅 1982 🏛 Springer 🌐 English ⚖ 199 KB

Capecitabine and mitomycin C as third-li

✍ Chong, G; Dickson, J L B; Cunningham, D; Norman, A R; Rao, S; Hill, M E; Price, 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 89 KB

The use of GTX as second-line and later

✍ Hassan K. Dakik; Daniel J. Moskovic; Peter J. Carlson; Eric P. Tamm; Wei Qiao; R 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 314 KB

Mitomycin C is an inactive drug in the t

✍ Dees, Ad; Verweij, Jaap; van Putten, Wim L.J.; Stoter, Gerrit 📂 Article 📅 1987 🏛 Elsevier Science ⚖ 488 KB